{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:31:41Z","timestamp":1780644701746,"version":"3.54.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jare.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T17:46:12Z","timestamp":1488217572000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review"],"prefix":"10.1016","volume":"8","author":[{"given":"Usama A.A.","family":"Sharaf El Din","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina O.","family":"Abdulazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2017.02.003_b0005","doi-asserted-by":"crossref","unstructured":"Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2(3): REVIEWS3005, 2001.","DOI":"10.1186\/gb-2001-2-3-reviews3005"},{"key":"10.1016\/j.jare.2017.02.003_b0010","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0015","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0020","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/ndt\/gfr596","article-title":"Residual renal function is an independent determinant of serum fgf-23 levels in dialysis patients","volume":"27","author":"Viaene","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jare.2017.02.003_b0025","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/ndt\/gfq089","article-title":"Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients","volume":"25","author":"Nasrallah","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jare.2017.02.003_b0030","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","article-title":"FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages","volume":"23","author":"Desjardins","year":"2012","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jare.2017.02.003_b0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.jare.2017.02.003_b0040","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/ndt\/gfq191","article-title":"Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?","volume":"25","author":"Olauson","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jare.2017.02.003_b0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2017.02.003_b0050","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves secondary hyperparathyroidism and osteodystrophy parameters yet exacerbates vascular calcification in chronic kidney disease rats","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2017.02.003_b0055","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ndt\/gfp784","article-title":"The role of FGF-23 in CKD\u2013MBD and cardiovascular disease: friend or foe?","volume":"25","author":"Larsson","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.jare.2017.02.003_b0060","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1172\/JCI64184","article-title":"Fibroblast growth factor 23: friend or foe in uremia?","volume":"122","author":"Moe","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2017.02.003_b0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jare.2017.02.003_b0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"2","key":"10.1016\/j.jare.2017.02.003_b0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J Biochem"},{"key":"10.1016\/j.jare.2017.02.003_b0080","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jare.2017.02.003_b0085","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxy-vitamin D3 production","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jare.2017.02.003_b0090","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2215\/CJN.07450714","article-title":"Vascular calcification in patients with nondialysis CKD over 3 years","volume":"10","author":"G\u00f3rriz","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.jare.2017.02.003_b0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000342794","article-title":"Carotid plaque, carotid intima-media thickness, and coronary calcification equally discriminate prevalent cardiovascular disease in kidney disease","volume":"36","author":"Adeseun","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0100","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/CIRCRESAHA.110.234146","article-title":"Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification","volume":"108","author":"New","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jare.2017.02.003_b0105","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCIMAGING.113.000382","article-title":"Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET\/CT study","volume":"6","author":"Abdelbaky","year":"2013","journal-title":"Circ Cardiovasc Imag"},{"issue":"4","key":"10.1016\/j.jare.2017.02.003_b0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5527\/wjn.v3.i4.143","article-title":"Why do young people with chronic kidney disease die early?","volume":"3","author":"Kumar","year":"2014","journal-title":"World J Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1525-139X.2002.00083.x","article-title":"Inflammation in end-stage renal disease: sources, consequences, and therapy","volume":"15","author":"Stenvinkel","year":"2002","journal-title":"Semin Dial"},{"key":"10.1016\/j.jare.2017.02.003_b0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000381990","article-title":"The gut as a source of inflammation in chronic kidney disease","volume":"130","author":"Lau","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.jare.2017.02.003_b0130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.jare.2017.02.003_b0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/ajkd.2003.50005","article-title":"An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis","volume":"41","author":"Stomp\u00f3r","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jare.2017.02.003_b0140","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/ndt\/gfl118","article-title":"Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis","volume":"21","author":"Jung","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.jare.2017.02.003_b0145","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.ASN.0000111744.00916.E6","article-title":"The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction","volume":"15","author":"Kaysen","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jare.2017.02.003_b0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nephro.2006.04.004","article-title":"New insights oninflammationin chronic kidney disease-genetic and non-genetic factors","volume":"2","author":"Stenvinkel","year":"2006","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.jare.2017.02.003_b0155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease","volume":"77","author":"Barreto","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jare.2017.02.003_b0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2369-14-22","article-title":"Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study","volume":"14","author":"Nakayama","year":"2013","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.jare.2017.02.003_b0165","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.1210\/jc.2011-2836","article-title":"Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study","volume":"97","author":"Schoppet","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jare.2017.02.003_b0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOP.0000000000000059","article-title":"Coronary artery calcification and cardiovascular disease in children with chronic kidney disease","volume":"26","author":"Paoli","year":"2014","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1016\/j.jare.2017.02.003_b0175","first-page":"17","article-title":"Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3\u20135D","volume":"45","author":"Zhang","year":"2015","journal-title":"Ann Clin Lab Sci Winter"},{"key":"#cr-split#-10.1016\/j.jare.2017.02.003_b0180.1","doi-asserted-by":"crossref","unstructured":"Zayed BE, El-Fishawy H, Al-Shihaby AR, Salem MA, Sharaf El Din UA, Salem MM. Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action. Egypt J Intern Med [serial online] [cited 2016 October 21]","DOI":"10.4103\/1110-7782.174928"},{"key":"#cr-split#-10.1016\/j.jare.2017.02.003_b0180.2","doi-asserted-by":"crossref","unstructured":"27:133-8. Available from: http:\/\/www.esim.eg.net\/text.asp?2015\/27\/4\/133\/174928, 2015.","DOI":"10.2308\/jmar-51060"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0185","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jare.2017.02.003_b0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000356118","article-title":"The association between fibroblast growth factor-23 and vascular calcification is mitigated by inflammation markers","volume":"3","author":"Nasrallah","year":"2013","journal-title":"Nephron Extra"},{"issue":"6","key":"10.1016\/j.jare.2017.02.003_b0195","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.jare.2017.02.003_b0200","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD","volume":"7","author":"Munoz Mendoza","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0205","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jare.2017.02.003_b0210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbrc.2016.03.138","article-title":"Wound healing delays in alpha-Klotho-deficient mice that have skin appearance similar to that in aged humans: study of delayed wound healing mechanism","volume":"473","author":"Yamauchi","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2017.02.003_b0215","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1248\/bpb.b14-00276","article-title":"Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice","volume":"38","author":"Masuda","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jare.2017.02.003_b0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1873-3468.12040","article-title":"Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages","volume":"590","author":"Han","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jare.2017.02.003_b0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.jare.2017.02.003_b0230","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","article-title":"Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli","volume":"399","author":"Ito","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jare.2017.02.003_b0235","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00223-016-0116-8","article-title":"Systemic inflammation affects human osteocyte-specific protein and cytokine expression","volume":"98","author":"Pathak","year":"2016","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.jare.2017.02.003_b0240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0245","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000362251","article-title":"Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease","volume":"39","author":"Seifert","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0250","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jare.2017.02.003_b0255","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","volume":"31","author":"Leifheit-Nestler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.jare.2017.02.003_b0260","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ndt\/gfs557","article-title":"FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease","volume":"28","author":"Ketteler","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.jare.2017.02.003_b0265","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0270","first-page":"1","article-title":"Patients with FGF23-related hypophosphatemic rickets\/osteomalacia do not present with left ventricular hypertrophy","volume":"18","author":"Takashi","year":"2016","journal-title":"Endocr Res"},{"issue":"9","key":"10.1016\/j.jare.2017.02.003_b0275","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0280","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.10331011","article-title":"FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy","volume":"7","author":"Lundberg","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF-23 as a predictor of renal outcome in diabetic nephropathy","volume":"6","author":"Titan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0290","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2215\/CJN.08680811","article-title":"Combined use of vitamin D status and FGF23 for risk stratification of renal outcome","volume":"7","author":"Nakano","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and CKD progression in African Americans","volume":"24","author":"Scialla","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0300","article-title":"Fibroblast growth Factor 23 and risk of CKD progression in children","volume":"25","author":"Portale","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jare.2017.02.003_b0305","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1681\/ASN.2014020218","article-title":"Serum fibroblast growth factor-23 is associated with incident kidney disease","volume":"26","author":"Rebholz","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.jare.2017.02.003_b0310","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jare.2017.02.003_b0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(98)00127-6","article-title":"Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein","volume":"424","author":"Shiraki-Iida","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jare.2017.02.003_b0325","first-page":"143","article-title":"Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane","volume":"565","author":"Imura","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jare.2017.02.003_b0330","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jare.2017.02.003_b0335","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12020-007-0016-9","article-title":"Anti-oxidative effect of Klotho on endothelial cells through cAMP activation","volume":"31","author":"Rakugi","year":"2007","journal-title":"Endocrine"},{"key":"10.1016\/j.jare.2017.02.003_b0340","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2005.11.094","article-title":"Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells","volume":"339","author":"Ikushima","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2017.02.003_b0345","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jare.2017.02.003_b0350","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","article-title":"Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism","volume":"18","author":"Kawata","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0355","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2017.02.003_b0360","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jare.2017.02.003_b0365","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","author":"Quarles","year":"2012","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jare.2017.02.003_b0370","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","article-title":"Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease","volume":"22","author":"de Borst","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0375","doi-asserted-by":"crossref","first-page":"e70775","DOI":"10.1371\/journal.pone.0070775","article-title":"Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor","volume":"8","author":"Zanchi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jare.2017.02.003_b0380","article-title":"Normal 25-hydroxyvitamin D levels are associated with less proteinuria and attenuate renal failure progression in children with CKD","author":"Shroff","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"May","key":"10.1016\/j.jare.2017.02.003_b0385","article-title":"Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis","volume":"24","author":"de Jong","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.jare.2017.02.003_b0390","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1681\/ASN.2014101009","article-title":"Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study","volume":"27","author":"Chonchol","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jare.2017.02.003_b0395","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0400","doi-asserted-by":"crossref","first-page":"C1036","DOI":"10.1152\/ajpcell.00215.2011","article-title":"Characterization of FGF receptor expression in human neutrophils and their contribution to chemotaxis","volume":"301","author":"Haddad","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jare.2017.02.003_b0405","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.05-5432fje","article-title":"Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process","volume":"20","author":"Razzaque","year":"2006","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.jare.2017.02.003_b0410","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0415","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/bmm.16.11","article-title":"Prognostic value ofFGF23among patients with end-stage renal disease: a systematic review and meta-analysis","volume":"10","author":"Yang","year":"2016","journal-title":"Biomark Med"},{"key":"10.1016\/j.jare.2017.02.003_b0420","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ki.2010.281","article-title":"FGF23 or PTH: which comes first in CKD?","volume":"78","author":"Isakova","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.jare.2017.02.003_b0425","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10157-014-0947-4","article-title":"Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease","volume":"18","author":"Goto","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jare.2017.02.003_b0430","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/nep.12319","article-title":"Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients","volume":"19","author":"Lin","year":"2014","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1016\/j.jare.2017.02.003_b0435","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1159\/000362424","article-title":"Effect of niacin on FGF23 concentration in chronic kidney disease","volume":"39","author":"Rao","year":"2014","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.jare.2017.02.003_b0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5414\/CN107764","article-title":"The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients","volume":"80","author":"Soriano","year":"2013","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.jare.2017.02.003_b0445","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000440968","article-title":"Administration of ferric citrate hydrate decreases circulating FGF23 levels independently of serum phosphate levels in hemodialysis patients with iron deficiency","volume":"131","author":"Iguchi","year":"2015","journal-title":"Nephron"},{"issue":"7","key":"10.1016\/j.jare.2017.02.003_b0450","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2215\/CJN.10941013","article-title":"The use of fibroblast growth factor 23 testing in patients with kidney disease","volume":"9","author":"Smith","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jare.2017.02.003_b0455","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jare.2017.02.003_b0460","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ndt\/gfr384","article-title":"Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism","volume":"27","author":"Koizumi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.jare.2017.02.003_b0465","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jare.2017.02.003_b0470","doi-asserted-by":"crossref","first-page":"G496","DOI":"10.1152\/ajpgi.00167.2004","article-title":"Regulation of intestinal phosphate transport. I. Segmental expression and adaptation to low-P(i) diet of the type IIb Na(+)-P(i) cotransporter in mouse small intestine","volume":"288","author":"Radanovic","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"10.1016\/j.jare.2017.02.003_b0475","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23","volume":"23","author":"Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0480","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/14.5.1195","article-title":"Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine","volume":"14","author":"Katai","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.jare.2017.02.003_b0485","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00279.2009","article-title":"Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate","volume":"297","author":"Giral","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jare.2017.02.003_b0490","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1681\/ASN.2015020117","article-title":"Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD","volume":"26","author":"Isakova","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jare.2017.02.003_b0495","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation ofcinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123217300279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123217300279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:42:27Z","timestamp":1761856947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123217300279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2090123217300279"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2017.02.003","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Production and hosting by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}